EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 356 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,439,000 | -20.1% | 28,735 | +0.4% | 0.03% | -22.2% |
Q2 2021 | $1,802,000 | -31.2% | 28,613 | +1.5% | 0.04% | -34.5% |
Q1 2021 | $2,620,000 | +11.4% | 28,200 | +7.4% | 0.06% | +1.9% |
Q4 2020 | $2,352,000 | +5.7% | 26,250 | +21.9% | 0.05% | -6.9% |
Q3 2020 | $2,225,000 | +3.0% | 21,536 | -21.1% | 0.06% | -7.9% |
Q2 2020 | $2,160,000 | +34.2% | 27,309 | -1.8% | 0.06% | +21.2% |
Q1 2020 | $1,609,000 | +1.6% | 27,808 | -5.3% | 0.05% | +30.0% |
Q4 2019 | $1,584,000 | +1.7% | 29,368 | -1.4% | 0.04% | -20.0% |
Q3 2019 | $1,558,000 | +7.9% | 29,793 | -0.3% | 0.05% | +8.7% |
Q2 2019 | $1,444,000 | -4.2% | 29,890 | +0.2% | 0.05% | -27.0% |
Q1 2019 | $1,507,000 | -19.6% | 29,825 | -5.6% | 0.06% | -30.8% |
Q4 2018 | $1,874,000 | -12.4% | 31,610 | -2.8% | 0.09% | -15.0% |
Q3 2018 | $2,140,000 | +29.4% | 32,505 | -0.8% | 0.11% | +24.4% |
Q2 2018 | $1,654,000 | -4.3% | 32,768 | -0.2% | 0.09% | -8.5% |
Q1 2018 | $1,729,000 | +16.7% | 32,833 | +3.0% | 0.09% | +1.1% |
Q4 2017 | $1,482,000 | – | 31,883 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |